<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H8C18484849824DD2B37C5F480E6F7E59" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>116 HR 3044 IH: Medical Device Sterilization Challenge Act of 2019</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2019-05-30</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">116th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 3044</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20190530">May 30, 2019</action-date><action-desc><sponsor name-id="L000563">Mr. Lipinski</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HSY00">Science, Space, and Technology</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such
			 provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To establish the Medical Device Sterilization Challenge, and for other purposes.</official-title></form>
	<legis-body id="H312C8E39235F46609330533455A6253B" style="OLC">
 <section id="HC32348B1B6364E1D9C124FE7022471C8" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Medical Device Sterilization Challenge Act of 2019</short-title></quote>.</text> </section><section id="HB1E5543028744FC0A0027D4455A3F856"><enum>2.</enum><header>Medical device sterilization challenges</header> <subsection id="HE62E54D8C49A4436A55162EA17B38F94"><enum>(a)</enum><header>Authority</header><text>Not later than 180 days after the date of enactment of this Act, the Commissioner of Food and Drugs shall establish a program to be known as <quote>Medical Device Sterilization Challenge</quote> for carrying out prize competitions described in this section under section 24 of the Stevenson-Wydler Technology Innovation Act of 1980 (<external-xref legal-doc="usc" parsable-cite="usc/15/3719">15 U.S.C. 3719</external-xref>) relating to sterilization of medical devices.</text>
 </subsection><subsection display-inline="no-display-inline" id="H55C3B70236B343A1A7E52FB6D807517F"><enum>(b)</enum><header>Prize competitions</header><text>In carrying out the program, the Director shall provide for prize competitions, including at least one prize competition to seek solutions with respect to each of the following goals:</text>
 <paragraph id="H67E8AC7514F04E7E83D1BD5BFFE2121A"><enum>(1)</enum><text>Reduction of the human health hazards associated with ethylene oxide sterilization, including through reduction of—</text>
 <subparagraph id="HFF5C59A5A51F45479BCA1C50D67895A3"><enum>(A)</enum><text>the exposure to workers in such facilities; and</text> </subparagraph><subparagraph id="HA90F9E9FF07D4DA09A3AA50E47E5A155"><enum>(B)</enum><text>environmental emissions of ethylene oxide.</text>
 </subparagraph></paragraph><paragraph id="H3D21B09F21914EA5B6D191741A06A800"><enum>(2)</enum><text>Reduction of the amount of time required to effectively sterilize devices by a factor of 2 or more to sterilize the same type and number of devices over commonly-used ethylene oxide technology without a proportional increase in cost.</text>
 </paragraph><paragraph id="H01BFC49EFDDA4B9696F923C1900E5E39"><enum>(3)</enum><text>Achievement of rapid implementation of new sterilization agents or methods that minimize conversion costs without decreasing facility throughput.</text>
 </paragraph><paragraph id="HC30C8B30156C4903974AA08FE6C83B6A"><enum>(4)</enum><text>Provision of new or improved approaches to measuring, monitoring, and controlling ethylene oxide emissions, including detection at very low levels.</text>
 </paragraph><paragraph id="H9245231B3B204D56821EE7F75072A2B9"><enum>(5)</enum><text>Analysis of public health risks of emissions from currently-available data with respect to emissions of public health or provision of—</text>
 <subparagraph id="H836956D6B79B4C76ABB69B750B0C558B"><enum>(A)</enum><text>new or improved tools that use data to better model emissions over time at the regional or local scale; or</text>
 </subparagraph><subparagraph id="HB85C89E311294DF3AB121AD196168B9E"><enum>(B)</enum><text>actionable information on the health and environmental impacts of ethylene oxide sterilization to government, industry, and members of the public.</text>
 </subparagraph></paragraph><paragraph id="H66E80BA7F60348E3A93BC2640880DE08"><enum>(6)</enum><text>Enabling of minimally disruptive conversion of exiting device sterilization facilities that use ethylene oxide to convert to less-toxic methods of sterilization.</text>
				</paragraph></subsection><subsection id="HC49A68D2C7174E96839AE052B6C18744"><enum>(c)</enum><header>Prize committees</header>
 <paragraph id="H50C17E0D4A4F44A2A7D71AA64775F249"><enum>(1)</enum><header>In general</header><text>The Director of the Center for Devices and Radiological Health shall assemble a prize committee with respect to each prize competition that shall define the scope and detail of, and provide the requirements for, the prize competitions under this section. Such committee shall be composed of—</text>
 <subparagraph id="HC100D9F72D3F4F64BCCC32F20899A3DC"><enum>(A)</enum><text>members from the Federal agency, department, or office that most appropriately corresponds with the topic of the prize competition, including—</text>
 <clause id="H6C582829258F433298564C78FB2B9697"><enum>(i)</enum><text>with respect to a prize competition under subsection (b)(1), the Director or designee of the National Institutes of Health;</text>
 </clause><clause id="HAF75B2902D2B45A2B4B6DEDF575211B9"><enum>(ii)</enum><text>with respect to a prize competition under paragraphs (2), (3), (5), and (6) of subsection (b), the Director or designee of the National Science Foundation; and</text>
 </clause><clause id="H44218A7A5E364B58BADE2E8C97292569"><enum>(iii)</enum><text>with respect to a prize competition under paragraphs (4) and (5) of subsection (b), the Administrator or designee of the Environmental Protection Agency; and</text>
 </clause></subparagraph><subparagraph id="HCA659FDFE9204AE1A4E4F6ECD9DFC457"><enum>(B)</enum><text>representatives of any other entities, as determined appropriate by the Director, including State and local governments and the private sector.</text>
 </subparagraph></paragraph><paragraph commented="no" id="HD7858B51DA124D6D8560F66A1DADEF2C"><enum>(2)</enum><header>Defining topic areas</header><text>The prize committee may modify and define the scope of the prize areas described under subsection (b), so long as such modification is in accordance with descriptions in such subsection.</text>
 </paragraph><paragraph id="HCB98F587B1A24CE8A75D1619D5546EC3"><enum>(3)</enum><header>Incentive for prize competition</header><text>The prize committee for each prize competition shall determine the incentive for such prize competition. In determining the incentive, the committee may consider—</text>
 <subparagraph id="H76155B0BC8A94C77A886EDB70265D7EA"><enum>(A)</enum><text>a cash prize;</text> </subparagraph><subparagraph id="HDA05A7DA9E884032BC1EE4206B5B3968"><enum>(B)</enum><text>access to Government facilities, a cooperative research and development agreement, or other method;</text>
 </subparagraph><subparagraph id="H2F517812412447189611FECCC68618FE"><enum>(C)</enum><text display-inline="yes-display-inline">with respect to for a product of use or promise to the Federal Government, a commitment by the Federal Government to purchase a set number of units of a product from at an agreed-upon price before the product is brought to market;</text>
 </subparagraph><subparagraph id="HBB3FA3E5E01845FB84A62CCE53C00DDC"><enum>(D)</enum><text>participation in entrepreneurship mentoring programs;</text> </subparagraph><subparagraph id="HA5B6A4C7F21245289B438561290CBE5B"><enum>(E)</enum><text>consultation and mentoring through the regulatory pathway towards approval for use; or</text>
 </subparagraph><subparagraph id="H5E05442F3CEC43E0BF42098B565D57B7"><enum>(F)</enum><text>any other incentive provided for by law.</text> </subparagraph></paragraph><paragraph id="H6DC54F8ABBD54F349520EFCF73FC357A"><enum>(4)</enum><header>Judging criteria</header><text>The prize committee for each prize competition shall establish judging criteria for the competition that shall include—</text>
 <subparagraph id="H5C4AF127C3834DA2B119F8DADFA24018"><enum>(A)</enum><text>potential for the solution to become a commercial product or service or advance knowledge to further the public good;</text>
 </subparagraph><subparagraph id="HDBB36DFBDE8F4B4396246C4B3F49A6ED"><enum>(B)</enum><text>consideration of how likely the solution is to lead to subsequent research, development, or manufacturing in the United States;</text>
 </subparagraph><subparagraph id="H63A74B0523D347D79D5D837268ADE760"><enum>(C)</enum><text>the degree to which the solution will reduce the public health burden created by ethylene oxide sterilization of medical devices; and</text>
 </subparagraph><subparagraph id="H8C8CE111A2D94E3881BAE898F69CDD58"><enum>(D)</enum><text>the degree to which the solution will reduce emissions and the environmental health burden created by ethylene oxide emissions from the sterilization of medical devices.</text>
 </subparagraph></paragraph><paragraph id="HBF5A726F3E874A0B8B33995F1F86D484"><enum>(5)</enum><header>Consideration</header><text>In carrying out this section, the committee shall take into consideration the best practices provided for in the challenges and prizes toolkit made publicly available on December 15, 2016, by the General Services Administration.</text>
 </paragraph></subsection><subsection id="H96DAE11A5894465982AEBA302FE68164"><enum>(d)</enum><header>Acceptance of funds</header><text>In addition to such sums as may be appropriated or otherwise made available to the Director to award prizes under this section, the Director may accept funds from other Federal agencies, and State and local governments to award prizes under this section.</text>
 </subsection><subsection id="H8E8D9E5DB1A44F1FB16F0A4EA2725FA8"><enum>(e)</enum><header>Eligibility</header><text>Notwithstanding section 24(g)(3) of the Stevenson-Wydler Technology Innovation Act of 1980 (<external-xref legal-doc="usc" parsable-cite="usc/15/3719">15 U.S.C. 3719(g)(3)</external-xref>), a group may be eligible for an award under this section if 1 member of such group is a citizen or permanent resident of the United States.</text>
 </subsection><subsection id="HBEA971D8828241918E983C2EC65C3111"><enum>(f)</enum><header>Completion of prize competitions</header><text>The prize competitions carried out under this section shall be completed not later than the date that is 5 years after the program is established under subsection (a).</text>
 </subsection><subsection id="HE67243E6EF68472FBF1A0FB2854B2340"><enum>(g)</enum><header>Authorization of appropriations</header><text>There is authorized to be appropriated $20,000,000 to carry out this section, to remain available until expended.</text>
			</subsection></section><section id="HABB3B939CA6B4EA293FD10A8212B4414"><enum>3.</enum><header>Agency Activities to Support Novel and Early-Stage Technology for Medical Device Sterilization</header>
 <subsection id="H8F211EEE6EA941588E442500F7B464F0"><enum>(a)</enum><header>National science foundation</header><text display-inline="yes-display-inline">During the 5 year period beginning on the date of the enactment of this Act, the National Science Foundation shall use existing authority to award grants on a competitive basis to investigator-initiated research projects that may lead to the development, implementation, and assessment of novel sterilization methods, including traineeships for those who perform this research in academic and industrial settings.</text>
 </subsection><subsection id="H6E6426A481ED4FBFB31497C342544DF2"><enum>(b)</enum><header>National institutes of health</header><text>The Director of the National Institutes of Health shall—</text> <paragraph id="H547E3F68734742E3A965F40696F2A260"><enum>(1)</enum><text>support or conduct research on the health effects of—</text>
 <subparagraph id="HD1F5BB65972643EC9BBAA01D5B6F9A9C"><enum>(A)</enum><text display-inline="yes-display-inline">novel sterilization methods, particularly those methods that are well-suited for materials for which ethylene oxide is currently the best available sterilization method, including research on the efficacy of the method on a broad range of materials commonly used in medical devices, on individuals who receive medical devices;</text>
 </subparagraph><subparagraph id="H863DFD3F8D984BCFA28B87E9ED8BDC98"><enum>(B)</enum><text>emissions from such novel sterilization methods on individuals in the surrounding communities; and</text> </subparagraph><subparagraph id="H42E4629D0C6D4E92BD0EB1F601B79D7C"><enum>(C)</enum><text>ethylene oxide, particularly on the morbidity secondary to occupational or environmental exposure at levels measured near sources that emit ethylene oxide; and</text>
 </subparagraph></paragraph><paragraph id="H5730A85F87D24EE6BB848749BD211AF3"><enum>(2)</enum><text>award grants, on a competitive basis, to enable institutions to support graduate students and postdoctoral fellows who perform research on novel sterilization methods in both academic and industry settings.</text>
 </paragraph></subsection><subsection id="HF8CF1754B5B3447988364E8354F19A06"><enum>(c)</enum><header>Environmental protection agency</header><text display-inline="yes-display-inline">The Environmental Protection Agency shall support or conduct research on how products, processes, and systems used to produce proposed alternatives to ethylene oxide sterilization will affect the environment.</text>
 </subsection></section><section id="HC1E9B09A5A6C47B19C906AAAD4E9FDFC"><enum>4.</enum><header>GAO Report</header><text display-inline="no-display-inline">Not later than 10 years after the implementation of this Act, the Comptroller General of the United States shall submit to Congress a report on the impact and the effectiveness of the provisions of this Act at achieving the goals described in subsection (b).</text>
		</section></legis-body></bill>


